Allurion Technologies Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.6152 USD
−28.75 M USD
15.23 M USD
13.18 M
About Allurion Technologies Inc.
Sector
Industry
CEO
Shantanu K. Gaur
Website
Headquarters
Natick
Founded
2009
Identifiers
3
ISIN US02008G1105
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Displays a symbol's price movements over previous years to identify recurring trends.